Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 1702 to 1751 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1702\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ELKS PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0412444\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.173407\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237847376\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ERC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1703\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26S PROTEASOME NON-ATPASE REGULATORY SUBUNIT 3 (26S PROTEASOME REGULATORY SUBUNIT S3) (PROTEASOME SUBUNIT P58). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.779642\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.27908\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237762421\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PSMD3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1704\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DJ408B20.3 (NOVEL PROTEIN SIMILAR TO 60S ACIDIC RIBOSOMAL PROTEIN P2 (RPLP2)). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0573148\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.241075\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237746759\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1705\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BETA-CENTRACTIN (ACTIN-RELATED PROTEIN 1B) (ARP1B). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0916612\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.385556\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237737709\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACTR1B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1706\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ALPHA-CENTRACTIN (CENTRACTIN) (CENTROSOME-ASSOCIATED ACTIN HOMOLOG) (ACTIN-RPV) (ARP1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0967911\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.407134\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237737698\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACTR1A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1707\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26S PROTEASE REGULATORY SUBUNIT 6B (MIP224) (MB67 INTERACTING PROTEIN) (TAT-BINDING PROTEIN-7) (TBP-7). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.848985\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.57194\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237681764\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PSMC4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1708\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VESICLE-FUSING ATPASE (EC 3.6.4.6) (VESICULAR-FUSION PROTEIN NSF) (N- ETHYLMALEIMIDE SENSITIVE FUSION PROTEIN) (NEM-SENSITIVE FUSION PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.15883\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.66831\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23765917\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NSF\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1709\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26S PROTEASE REGULATORY SUBUNIT 7 (MSS1 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.933253\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.92714\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237641897\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PSMC2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1710\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60S RIBOSOMAL PROTEIN L4 (L1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.83123\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.49797\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237632112\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPL4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1711\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.18248\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.768033\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237593958\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PNPLA7\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1712\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26S PROTEASOME NON-ATPASE REGULATORY SUBUNIT 11 (26S PROTEASOME REGULATORY SUBUNIT S9) (26S PROTEASOME REGULATORY SUBUNIT P44.5). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.667497\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.81169\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237400638\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PSMD11\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1713\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26S PROTEASOME NON-ATPASE REGULATORY SUBUNIT 6 (26S PROTEASOME REGULATORY SUBUNIT S10) (P42A) (PROTEASOME REGULATORY PARTICLE SUBUNIT P44S10). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.750885\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.16322\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237379948\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PSMD6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1714\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"NUCLEOLAR PROTEIN FAMILY A, MEMBER 2; COMPONENT OF THE H/ACA SNORNP. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0909039\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.382985\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237356293\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NOLA2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1715\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"TRANSCRIPTION INITIATION FACTOR IIF, ALPHA SUBUNIT (TFIIF-ALPHA) (TRANSCRIPTION INITIATION FACTOR RAP74). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0303013\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.127662\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237355674\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GTF2F1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1716\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR PROTON TRANSLOCATING ATPASE 116 KDA SUBUNIT A ISOFORM 1 (CLATHRIN-COATED VESICLE/SYNAPTIC VESICLE PROTON PUMP 116 KDA SUBUNIT) (VACUOLAR PROTON PUMP SUBUNIT 1) (VACUOLAR ADENOSINE TRIPHOSPHATASE SUBUNIT AC116). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.269961\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.13756\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237315834\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP6V0A1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1717\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ATPASE, H+ TRANSPORTING, LYSOSOMAL V0 SUBUNIT A ISOFORM 4; VACUOLAR PROTON PUMP 116 KDA ACCESSORY SUBUNIT; VACUOLAR PROTON PUMP, SUBUNIT 2; H(+)-TRANSPORTING TWO-SECTOR ATPASE, NONCATALYTIC ACCESSORY PROTEIN 1B; ATPASE, H+ TRANSPORTING, LYSOSOMAL (VACUOLA"\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.224133\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.944489\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237306099\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP6V0A4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1718\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR PROTON TRANSLOCATING ATPASE 116 KDA SUBUNIT A ISOFORM 2 (V-ATPASE 116-KDA ISOFORM A2) (TJ6). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.211834\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.892673\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237303021\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP6V0A2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1719\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR PROTON TRANSLOCATING ATPASE 116 KDA SUBUNIT A ISOFORM 3 (V- ATPASE 116-KDA ISOFORM A3) (OSTEOCLASTIC PROTON PUMP 116 KDA SUBUNIT) (OC-116 KDA) (OC116) (T-CELL IMMUNE REGULATOR 1) (T CELL IMMUNE RESPONSE CDNA7 PROTEIN) (TIRC7). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.202198\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.852079\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237299593\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TCIRG1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1720\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MIDASIN (MIDAS-CONTAINING PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.321031\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.35288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237294512\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MDN1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1721\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26S PROTEASOME NON-ATPASE REGULATORY SUBUNIT 9 (26S PROTEASOME REGULATORY SUBUNIT P27). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.154828\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.652697\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237212673\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PSMD9\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1722\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PROBABLE DIMETHYLADENOSINE TRANSFERASE (EC 2.1.1.-) (S- ADENOSYLMETHIONINE-6-N',N'-ADENOSYL(RRNA) DIMETHYLTRANSFERASE) (18S RRNA DIMETHYLASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.367472\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.54946\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237161334\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DIMT1L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1723\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR PROTEIN SORTING-ASSOCIATED PROTEIN 45 (H-VPS45) (HLVPS45). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.230384\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.971531\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237134996\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
VPS45\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1724\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0547796\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.231086\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237052872\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RIOK2\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1725\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.10685\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.450769\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.23703937\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
VPS25\vspace{3pt}}\\\cline{1-1}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1726\vspace{3pt}}&&&&&\parbox{\wcF}{\vspace{3pt}\noindent
CHMP6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1727\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"GLUTAMATE DECARBOXYLASE, 65 KDA ISOFORM (EC 4.1.1.15) (GAD-65) (65 KDA GLUTAMIC ACID DECARBOXYLASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0175982\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0742417\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237039292\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GAD2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1728\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0787698\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.332307\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237039244\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C12orf26\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1729\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"GAMMA-SOLUBLE NSF ATTACHMENT PROTEIN (SNAP-GAMMA) (N-ETHYLMALEIMIDE- SENSITIVE FACTOR ATTACHMENT PROTEIN, GAMMA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.056545\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.238547\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237039242\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NAPG\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1730\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NOSTRIN. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.02137\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.0901539\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.237039108\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
NOSTRIN\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1731\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1732\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"GLUTAMATE DECARBOXYLASE, 67 KDA ISOFORM (EC 4.1.1.15) (GAD-67) (67 KDA GLUTAMIC ACID DECARBOXYLASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0213112\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0899059\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237038949\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GAD1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1733\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"LIV-1 PROTEIN, ESTROGEN REGULATED. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0166846\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0703876\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23703891\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SLC39A6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1734\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EAP30 SUBUNIT OF ELL COMPLEX. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.04274\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.180308\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237038845\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SNF8\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1735\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAD54-LIKE PROTEIN; RAD54 HOMOLOG. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.180241\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.760447\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.237019805\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RAD54L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1736\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.630807\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.66198\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236969098\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATPBD3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1737\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLUTAMINYL-TRNA SYNTHASE (GLUTAMINE-HYDROLYZING)-LIKE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.094576\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.399107\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236969033\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
QRSL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1738\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FATTY-ACID AMIDE HYDROLASE (EC 3.1.-.-) (OLEAMIDE HYDROLASE) (ANANDAMIDE AMIDOHYDROLASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0947181\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.399707\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.23696883\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FAAH\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1739\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"URACIL-DNA GLYCOSYLASE, MITOCHONDRIAL PRECURSOR (EC 3.2.2.-) (UDG). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0946707\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.399507\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.236968814\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
UNG\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1740\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PROBABLE GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE SUBUNIT B, MITOCHONDRIAL PRECURSOR (EC 6.3.5.-) (GLU-ADT SUBUNIT B) (CYTOCHROME OXIDASE ASSEMBLY FACTOR PET112 HOMOLOG). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
PET112L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1741\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COACTOSIN-LIKE PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0315727\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.133236\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236968237\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
COTL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1742\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CONSERVED OLIGOMERIC GOLGI COMPLEX COMPONENT 6. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0676104\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.2855\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236814011\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
COG6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1743\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40S RIBOSOMAL PROTEIN S28. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.229236\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.968071\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236796681\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1744\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"VACUOLAR ATP SYNTHASE SUBUNIT B, BRAIN ISOFORM (EC 3.6.3.14) (V-ATPASE B2 SUBUNIT) (VACUOLAR PROTON PUMP B ISOFORM 2) (ENDOMEMBRANE PROTON PUMP 58 KDA SUBUNIT) (HO57). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.357744\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.51127\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236717463\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP6V1B2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1745\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 1-LIKE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0826697\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.349234\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236717215\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GDAP1L1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1746\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
YEAST SEC31P HOMOLOG. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.134029\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.566199\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236717126\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SEC31A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1747\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR ATP SYNTHASE SUBUNIT E (EC 3.6.3.14) (V-ATPASE E SUBUNIT) (VACUOLAR PROTON PUMP E SUBUNIT) (V-ATPASE 31 KDA SUBUNIT) (P31). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.480242\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.02876\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236717009\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP6V1E1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1748\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0973611\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.411298\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236716687\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GDAP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1749\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR ATP SYNTHASE SUBUNIT D (EC 3.6.3.14) (V-ATPASE D SUBUNIT) (VACUOLAR PROTON PUMP D SUBUNIT) (V-ATPASE 28 KDA ACCESSORY PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.518099\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.18869\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236716483\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP6V1D\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1750\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR ATP SYNTHASE SUBUNIT H (EC 3.6.3.14) (V-ATPASE H SUBUNIT) (VACUOLAR PROTON PUMP H SUBUNIT) (V-ATPASE 50/57 KDA SUBUNITS) (VACUOLAR PROTON PUMP SUBUNIT SFD) (CGI-11). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0562476\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.237616\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236716383\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ATP6V1H\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1751\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VACUOLAR ATP SYNTHASE SUBUNIT G 2 (EC 3.6.3.14) (V-ATPASE G SUBUNIT 2) (VACUOLAR PROTON PUMP G SUBUNIT 2) (V-ATPASE 13 KDA SUBUNIT 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0861167\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.363797\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.236716356\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/